BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 19825192)

  • 1. Establishment of canine hemangiosarcoma xenograft models expressing endothelial growth factors, their receptors, and angiogenesis-associated homeobox genes.
    Kodama A; Sakai H; Matsuura S; Murakami M; Murai A; Mori T; Maruo K; Kimura T; Masegi T; Yanai T
    BMC Cancer; 2009 Oct; 9():363. PubMed ID: 19825192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of vascular endothelial growth factor, basic fibroblast growth factor, and their receptors (flt-1, flk-1, and flg-1) in canine vascular tumors.
    Yonemaru K; Sakai H; Murakami M; Yanai T; Masegi T
    Vet Pathol; 2006 Nov; 43(6):971-80. PubMed ID: 17099154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical demonstration of angiogenesis-associated homeobox proteins in canine vascular tumours.
    Kodama A; Sakai H; Murakami M; Murai A; Mori T; Maruo K; Yanai T; Masegi T
    J Comp Pathol; 2009; 141(2-3):199-203. PubMed ID: 19505696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutive phosphorylation of the mTORC2/Akt/4E-BP1 pathway in newly derived canine hemangiosarcoma cell lines.
    Murai A; Asa SA; Kodama A; Hirata A; Yanai T; Sakai H
    BMC Vet Res; 2012 Jul; 8():128. PubMed ID: 22839755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-12 inhibits tumor growth in a novel angiogenesis canine hemangiosarcoma xenograft model.
    Akhtar N; Padilla ML; Dickerson EB; Steinberg H; Breen M; Auerbach R; Helfand SC
    Neoplasia; 2004; 6(2):106-16. PubMed ID: 15140399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of microvessel density and the expression of the angiogenic factors VEGF, bFGF and the receptors Flt-1 and FLK-1 in benign, premalignant and malignant prostate tissues.
    Pallares J; Rojo F; Iriarte J; Morote J; Armadans LI; de Torres I
    Histol Histopathol; 2006 Aug; 21(8):857-65. PubMed ID: 16691538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HOXB7: a key factor for tumor-associated angiogenic switch.
    Carè A; Felicetti F; Meccia E; Bottero L; Parenza M; Stoppacciaro A; Peschle C; Colombo MP
    Cancer Res; 2001 Sep; 61(17):6532-9. PubMed ID: 11522651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basic fibroblast growth factor induces VEGF expression in chondrosarcoma cells and subsequently promotes endothelial progenitor cell-primed angiogenesis.
    Tzeng HE; Chen PC; Lin KW; Lin CY; Tsai CH; Han SM; Teng CL; Hwang WL; Wang SW; Tang CH
    Clin Sci (Lond); 2015 Jul; 129(2):147-58. PubMed ID: 25735814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis.
    von Marschall Z; Scholz A; Cramer T; Schäfer G; Schirner M; Oberg K; Wiedenmann B; Höcker M; Rosewicz S
    J Natl Cancer Inst; 2003 Mar; 95(6):437-48. PubMed ID: 12644537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparanase and basic fibroblast growth factor are co-expressed in malignant mesothelioma.
    Davidson B; Vintman L; Zcharia E; Bedrossian C; Berner A; Nielsen S; Ilan N; Vlodavsky I; Reich R
    Clin Exp Metastasis; 2004; 21(5):469-76. PubMed ID: 15672872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual blockade of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (FGF-2) exhibits potent anti-angiogenic effects.
    Li D; Xie K; Zhang L; Yao X; Li H; Xu Q; Wang X; Jiang J; Fang J
    Cancer Lett; 2016 Jul; 377(2):164-73. PubMed ID: 27130666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of platelet-derived growth factor and its receptors in spontaneous canine hemangiosarcoma and cutaneous hemangioma.
    Asa SA; Murai A; Murakami M; Hoshino Y; Mori T; Maruo K; Khater A; El-Sawak A; el-Aziz EA; Yanai T; Sakai H
    Histol Histopathol; 2012 May; 27(5):601-7. PubMed ID: 22419024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-angiogenic effects of somatostatin receptor subtype 2 on human pancreatic cancer xenografts.
    Kumar M; Liu ZR; Thapa L; Qin RY
    Carcinogenesis; 2004 Nov; 25(11):2075-81. PubMed ID: 15205362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiogenic growth factor expression in benign and malignant vascular tumours.
    Young RJ; Fernando M; Hughes D; Brown NJ; Woll PJ
    Exp Mol Pathol; 2014 Aug; 97(1):148-53. PubMed ID: 24984271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development.
    Samaniego F; Markham PD; Gendelman R; Watanabe Y; Kao V; Kowalski K; Sonnabend JA; Pintus A; Gallo RC; Ensoli B
    Am J Pathol; 1998 Jun; 152(6):1433-43. PubMed ID: 9626048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of heat shock protein 27 induces long-term dormancy in human breast cancer.
    Straume O; Shimamura T; Lampa MJ; Carretero J; Øyan AM; Jia D; Borgman CL; Soucheray M; Downing SR; Short SM; Kang SY; Wang S; Chen L; Collett K; Bachmann I; Wong KK; Shapiro GI; Kalland KH; Folkman J; Watnick RS; Akslen LA; Naumov GN
    Proc Natl Acad Sci U S A; 2012 May; 109(22):8699-704. PubMed ID: 22589302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VEGF, bFGF and their receptors at the fetal-maternal interface of the rhesus monkey.
    Wei P; Yu FQ; Chen XL; Tao SX; Han CS; Liu YX
    Placenta; 2004; 25(2-3):184-96. PubMed ID: 14972451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plexin-A4 promotes tumor progression and tumor angiogenesis by enhancement of VEGF and bFGF signaling.
    Kigel B; Rabinowicz N; Varshavsky A; Kessler O; Neufeld G
    Blood; 2011 Oct; 118(15):4285-96. PubMed ID: 21832283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow angiogenic ability and expression of angiogenic cytokines in myeloma: evidence favoring loss of marrow angiogenesis inhibitory activity with disease progression.
    Kumar S; Witzig TE; Timm M; Haug J; Wellik L; Kimlinger TK; Greipp PR; Rajkumar SV
    Blood; 2004 Aug; 104(4):1159-65. PubMed ID: 15130943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dimethylarginine dimethylaminohydrolase-1 (DDAH1) is frequently upregulated in prostate cancer, and its overexpression conveys tumor growth and angiogenesis by metabolizing asymmetric dimethylarginine (ADMA).
    Reddy KRK; Dasari C; Duscharla D; Supriya B; Ram NS; Surekha MV; Kumar JM; Ummanni R
    Angiogenesis; 2018 Feb; 21(1):79-94. PubMed ID: 29150732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.